PatternsRadar
Sign in

SHUKRAMEDSHUKRAMED

NSE
84.16INR+1.94 (+2.36%)Close · 20 Nov 2026
4 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹3,700 CrMarket cap
—P/E (TTM)
49.1%Delivery

Filings & corporate actions

1 results filed
CSV
Dividend
₹0.01 per share · last 21 Sept 2026
2026
  • 4 NovresultsResults · Q2 FY27 · consolidated and standalone0.0%NSE
  • 21 OctshareholdingShareholding · 30 Sept 2026-0.4%NSE
  • 21 SeptdividendDividend · ₹0.01 per share · record 21 Sept 2026-1.1%

Reaction to results · all yearsrose on day 0 in 0 of 1 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY274 Nov 20260.0%+2.9%—0.6×
Average0.0%+2.9%—

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open81.00
Day range80.30 – 84.80
52-week range—
From 52w high—
RSI (14)81.5
ATR (14)3.44
Volume40.64L
Avg volume (20D)70.09L
Rel volume0.58×
Volatility (1Y)50.6%
Turnover₹33.9Cr
Traded value (NSE)₹33.9Cr
VWAP83.36
SMA 50 / 20068.77 / —
Price band20%

Delivery percentage

Latest · 20 Nov 202649.1%
20-day avg36.6%
1-year avg40.3%
Percentile (own history)68th
Range7.9–71.2%
Sessions68

Over the last 20 sessions SHUKRAMED settled 36.6% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 40.3%, so recent sessions are running 3.7 points lower than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.01%
Dividend, trailing 12M₹0.01
Paid every year for1 yr
Shareholders35.0K
Net bulk deals, 30D-0.01%
Block deals, 30D₹0
Last bulk buy22 days ago

Performance returns

1D1W1M3M6M1Y
Price+2.36%+2.35%+34.59%+94.23%——

Valuation

Market cap₹3,700 Cr
Market cap (NSE)₹3,700 Cr
Free-float cap₹1,807 Cr
P/E (TTM)—
EPS (TTM)—
P/B31.4
Net margin (TTM)—
Other income / PBT—
ROE—
Debt / equity0.19
Shares outstanding44.08Cr
Listed14 Aug 2026

Ownership

Promoter51.15%
Promoter Δ QoQ—
Public48.85%
FII0.44%
DII0.22%
Pledged0.00%

Quarterly results · consolidated

Q2 FY27
Revenue (₹ Cr)44.2
YoY chg—
Net profit (₹ Cr)12.7
YoY chg—
Net margin28.8%
EPS0.29

Shareholding over time

One quarter on file; a trend needs two.

Promoter
51.15%
Public
48.85%
Promoter change
—
Filed
21 Oct 2026
FII
0.44%
DII
0.22%
Promoter pledged
0.00%

Who the public is

Mutual funds
0.00%
Insurance
0.00%
FPI
0.43%
Retail ≤ ₹2L
7.58%
HNI > ₹2L
2.07%
NRI
36.88%
Bodies corporate
0.73%
Shareholders
35,007

Major holders

As of 30 Sept 2026
HolderTypeHolding
RENUKA YOGESH PARIKHIndividual19.11%
ANAR PROJECT PRIVATE LIMITEDPromoter · Corporate18.71%
YOGESH BIHARILAL PARIKHIndividual17.56%
PARSHVA TEXCHEM INDIA PRIVATE LTD.Promoter · Corporate17.38%
NAVKAR SURGICAL GUJARATPromoter · Corporate11.74%
DAKSHESH RAMESHCHANDRA SHAHPromoter · Individual1.11%
ANAR JAYESHBHAI PATELPromoter · Individual0.99%
SUJAY JYOTINDRA MEHTAPromoter · Individual0.71%
PAYAL SUJAY MEHTAPromoter · Individual0.52%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 21 Sept 2026 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹0.01₹0.01
Ex-dateRecord dateDeclaredAdjusted
21 Sept 202621 Sept 2026₹0.01₹0.01

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Bulk & block deals · 29 Oct 2026

CSV
10 of 10 deals
By year
DateDealClientQuantityPriceValue
29 Oct 2026Buy · bulkQE SECURITIES LLP · as SHUKRAPHAR26.99L76.33₹20.6Cr
29 Oct 2026Sell · bulkQE SECURITIES LLP · as SHUKRAPHAR26.92L76.40₹20.6Cr
23 Oct 2026Sell · bulkHRTI PRIVATE LIMITED · as SHUKRAPHAR34.27L57.74₹19.8Cr
23 Oct 2026Buy · bulkHRTI PRIVATE LIMITED · as SHUKRAPHAR33.69L56.81₹19.1Cr
5 Oct 2026Buy · bulkHRTI PRIVATE LIMITED · as SHUKRAPHAR37.01L69.23₹25.6Cr
5 Oct 2026Sell · bulkHRTI PRIVATE LIMITED · as SHUKRAPHAR33.95L69.19₹23.5Cr
5 Oct 2026Sell · bulkQE SECURITIES LLP · as SHUKRAPHAR31.62L69.10₹21.9Cr
5 Oct 2026Buy · bulkQE SECURITIES LLP · as SHUKRAPHAR31.08L68.78₹21.4Cr
5 Oct 2026Sell · bulkALPHAGREP SECURITIES PRIVATE LIMITED · as SHUKRAPHAR29.60L68.67₹20.3Cr
5 Oct 2026Buy · bulkALPHAGREP SECURITIES PRIVATE LIMITED · as SHUKRAPHAR29.60L68.63₹20.3Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 16 Nov 2026 — P/E above 50 on the last four quarters’ earnings.
  • Price move > 50% in 3 months · since 11 Nov 2026 — One of the criteria NSE’s surveillance watches: price move > 50% in 3 months.
  • Price move > 90% in 3 months · since 2 Nov 2026 — One of the criteria NSE’s surveillance watches: price move > 90% in 3 months.
  • High-low range > 75% in 3 months · since 14 Oct 2026 — One of the criteria NSE’s surveillance watches: high-low range > 75% in 3 months.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
 Q2 FY27
Revenue from operations44.2
Other income0.6
Total income44.8
Total expenses26.9
└ Finance costs0.3
└ Depreciation1.1
Profit before tax17.8
Tax expense5.1
Net profit12.7
EPS0.29
Net margin28.76%
PBT margin40.33%
Tax rate28.70%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.

1 quarter on file; a year-on-year comparison needs five.

Balance sheet & cash flow · half-yearly

₹ crore, as filed

Balance sheet

 H1 FY27
Total assets175.3
Current assets128.3
└ Cash & equivalents0.0
└ Other bank balances11.0
└ Current investments0.0
└ Trade receivables38.7
└ Inventories23.4
Total equity117.9
└ Attributable to owners117.9
└ Share capital44.1
Borrowings22.5
└ Current12.9
└ Non-current9.6
Trade payables12.9
Current liabilities45.8
Total liabilities57.4
Net debt11.5
Debt / equity0.19
Current ratio2.80

Cash flow, year to date

 H1 FY27
Operating cash flow0.4
└ Capex(15.6)
Free cash flow(15.1)
Investing cash flow(15.3)
Financing cash flow19.9
└ Dividends paid0.0
└ Buybacks0.0
Net change in cash5.0

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SHUKRAMED at a glance

  • SHUKRAMED closed at ₹84.16 on 20 Nov 2026, +2.36% on the day.
  • Delivery was 49.1% of traded quantity on 20 Nov 2026, the 68th percentile of its own 68 sessions with a reading (20-session average 36.6%, 1-year average 40.3%).
  • Market capitalisation is ₹3,700 crore, with no positive trailing earnings for a P/E.
  • Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹44 crore, net profit ₹13 crore; the price moved 0.0% on the first session after.
  • Promoters held 51.15% at 30 Sept 2026.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE551C01044
SeriesEQ
Listed14 Aug 2026
Former symbolsSHUKRAPHAR (until 20 Nov 2026)
Former namesShukra Pharmaceuticals Limited (until 20 Nov 2026)
NSE market cap · 17 Nov 2026₹3,616 Cr
Free-float market cap (NSE)₹1,766 Cr
Shares outstanding (NSE)43.96Cr
History from14 Aug 2026
Sessions68
Turnover rank#419

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.